Fundraising FoxPermanence Bio Anti-Cancer Drugs
3 known investors
Find your way into Permanence Bio Anti-Cancer Drugs
1,105 people in our graph can introduce you to the Permanence Bio Anti-Cancer Drugs team.
Sign up to see every warm intro you have to Permanence Bio Anti-Cancer Drugs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Permanence Bio Anti-Cancer Drugs team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Permanence Bio is a biotech company developing therapies aimed at cancer prevention by protecting the genome from damage, drawing on aging and DNA repair research. It works to discover cancer-preventing compounds and advance lead compounds from mechanism of action through IND-enabling studies and into the clinic.
Founders & leadership
AT
Investors · 3
.jpeg){kind=logo}
Impatient Ventureslisted by Impatient VenturesVenicevia Jack Dreifuss · inferred
How we know: the VCSheet dataset · Not right? Tell us
Spacecadet Ventureslisted by Spacecadet VenturesKent County · $100K – $500K
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Permanence Bio Anti-Cancer Drugs do?
- Permanence Bio is a biotech company developing therapies aimed at cancer prevention by protecting the genome from damage, drawing on aging and DNA repair research. It works to discover cancer-preventing compounds and advance lead compounds from mechanism of action through IND-enabling studies and into the clinic.
- Who are Permanence Bio Anti-Cancer Drugs's investors?
- Permanence Bio Anti-Cancer Drugs's investors include Impatient Ventures, NFX, Spacecadet Ventures.